Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy
- 20 October 2020
- journal article
- research article
- Published by Wiley in Oral Diseases
- Vol. 27 (6) , 1564-1571
Abstract
Objectives: To investigate whether serum amylase can predict the recovery of salivary volume and determine the correlation of the level of cytokines, including epidermal growth factor, hepatocyte growth factor and keratinocyte growth factor, with oral mucositis during chemoradiotherapy for oral cancer.Subjects and Methods: This study included 84 patients treated with preoperative chemoradiotherapy followed by curative surgery, following a phase II study protocol. We measured and analysed the correlation of the stimulated saliva volume, serum amylase and cytokines in resting saliva at baseline and 1 month after chemoradiotherapy with oral mucositis levels.Results: We observed a negative correlation between the serum amylase level at the beginning of chemoradiotherapy and the stimulated saliva volume at 1 month after chemoradiotherapy (p = .03). Epidermal growth factor in resting saliva was significantly reduced after chemoradiotherapy (p < .01). The incidence of severe oral mucositis during chemoradiotherapy was significantly higher and negatively associated with the epidermal growth factor and keratinocyte growth factor levels (p = .04, p = .05).Conclusions: The serum amylase level at the beginning of chemoradiotherapy may be a predictor of the recovery of the saliva volume. Furthermore, cytokines such as epidermal growth factor and keratinocyte growth factor in resting saliva affect the development of oral mucositis during chemoradiotherapy.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP18K09771, JP15K20546, JP17K11878)
This publication has 37 references indexed in Scilit:
- Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinomaCancer Chemotherapy and Pharmacology, 2013
- Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignanciesRadiation Oncology, 2012
- Longitudinal Changes over 2 Years in Parotid Glands of Patients Treated with Preoperative 30-Gy Irradiation for Oral CancerJapanese Journal of Clinical Oncology, 2011
- Radiation-induced Parotid Gland Changes in Oral Cancer Patients: Correlation Between Parotid Volume and Saliva ProductionJapanese Journal of Clinical Oncology, 2009
- Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancerCancer, 2009
- Longitudinal evaluation of the oral mucositis weekly questionnaire‐head and neck cancer, a patient‐reported outcomes questionnaireCancer, 2007
- Oral mucositis in patients undergoing radiation treatment for head and neck carcinomaCancer, 2005
- Radiation-induced changes in cellularity and proliferation in human oral mucosaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositisBritish Journal of Cancer, 2000
- Sialochemistry in Diseases and Clinical Situations Affecting Salivary GlandsCRC Critical Reviews in Clinical Laboratory Sciences, 1980